Kamada Ltd
NASDAQ:KMDA
Kamada Ltd
Net Income (Common)
Kamada Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kamada Ltd
NASDAQ:KMDA
|
Net Income (Common)
$8.3m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
34%
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Net Income (Common)
-$7m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Net Income (Common)
-$60.6m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-14%
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Net Income (Common)
-$102.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Net Income (Common)
-$8.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Net Income (Common)
-₪31m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
See Also
What is Kamada Ltd's Net Income (Common)?
Net Income (Common)
8.3m
USD
Based on the financial report for Dec 31, 2023, Kamada Ltd's Net Income (Common) amounts to 8.3m USD.
What is Kamada Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
34%
The average annual Net Income (Common) growth rates for Kamada Ltd have been -21% over the past three years , -18% over the past five years , and 34% over the past ten years .